AXVNX
Price
$22.49
Change
-$0.04 (-0.18%)
Updated
Jul 31 closing price
Net Assets
35.33M
DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
Interact to see
Advertisement

AXVNX vs DFSVX

AXVNX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
AXVNX vs. DFSVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXVNX is a Buy and DFSVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. AXVNX (35.3M). DFSVX pays higher dividends than AXVNX: DFSVX (1.50) vs AXVNX (1.19). AXVNX was incepted earlier than DFSVX: AXVNX (8 years) vs DFSVX (33 years). AXVNX (1.42) is less costly to investors than DFSVX (0.31). AXVNX is a more actively managed with annual turnover of: 57.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than AXVNX: DFSVX (0) vs AXVNX (5000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. AXVNX (28.71). DFSVX return over 5 years is better than : 50.66 vs. AXVNX (47.35).
AXVNXDFSVXAXVNX / DFSVX
Total Expense Ratio0.730.31235%
Annual Report Gross Expense Ratio1.420.31458%
Fund Existence8 years33 years-
Gain YTD19.31021.33691%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.3M19.5B0%
Annual Yield % from dividends1.191.5079%
Returns for 1 year28.7134.3983%
Returns for 3 years30.8650.3761%
Returns for 5 years47.3550.6693%
Returns for 10 yearsN/A107.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I